157 related articles for article (PubMed ID: 15759034)
21. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.
López C; Delgado J; Costa D; Conde L; Ghita G; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Baumann T; Rozman M; Aymerich M; Colomer D; Cobo F; Campo E; López-Guillermo A; Montserrat E; Carrió A
Genes Chromosomes Cancer; 2012 Sep; 51(9):881-9. PubMed ID: 22619094
[TBL] [Abstract][Full Text] [Related]
22. Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia.
O'Malley DP; Giudice C; Chang AS; Chang D; Barry TS; Hibbard MK; Chen R; Chen ST
Int J Lab Hematol; 2011 Jun; 33(3):238-44. PubMed ID: 21143592
[TBL] [Abstract][Full Text] [Related]
23. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
24. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
Lu G; Kong Y; Yue C
Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
[TBL] [Abstract][Full Text] [Related]
25. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M
Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436
[TBL] [Abstract][Full Text] [Related]
26. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
[TBL] [Abstract][Full Text] [Related]
27. [Apoptosis in chronic lymphocytic leukemia].
Giordano M
Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
[TBL] [Abstract][Full Text] [Related]
28. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.
Plander M; Seegers S; Ugocsai P; Diermeier-Daucher S; Iványi J; Schmitz G; Hofstädter F; Schwarz S; Orsó E; Knüchel R; Brockhoff G
Leukemia; 2009 Nov; 23(11):2118-28. PubMed ID: 19657365
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
32. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
[TBL] [Abstract][Full Text] [Related]
33. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
34. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
35. [Methods in molecular cytogenetics for determination of prognostically important chromosome changes in patients with chronic lymphatic leukemias].
Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
Cas Lek Cesk; 2000 Sep; 139(18):564-9. PubMed ID: 11109291
[TBL] [Abstract][Full Text] [Related]
36. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
38. Improvement of cytogenetic results in B-cell chronic lymphocytic leukemia using immuno-purified leukemic cells.
Brizard A; Brizard F; Lessard M; Dreyfus B; Guilhot F; Tanzer J
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):103-5. PubMed ID: 8511032
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
40. [Lymphocyte immunophenotyping and cytogenetics for more precise prognosis in patients with type B chronic lymphatic leukemia].
Cmunt E; Michalová K; Karban J; Zemanová Z; Sindelárová L; Bosáková Z; Brezinová J; Kurková S; Schwarz J
Cas Lek Cesk; 2003 Feb; 142(2):106-11. PubMed ID: 12698539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]